MOSCOW (Reuters) – Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia’s Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
RDIF did not say when production would begin.
(Reporting by Vladimir Soldatkin; Writing by Alexander Marrow, ediitng by Emelia Sithole-Matarise)
